PUBLIC CONTRACT · 2025
: Ajuste direto para aquisição de O4 - OCTREOTIDO [0,1 MG/1ML; F/AMP] para suprir necessidades na área da saúde
- Contract value
- €598.46
- Signed on
- 2 January 2025
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11470926PUBLISHED SUBJECT
: Ajuste direto para aquisição de O4 - OCTREOTIDO [0,1 MG/1ML; F/AMP] para suprir necessidades na área da saúde
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PHARMIS BIOFARMACEUTICA, LDA. · Tax ID 502595442
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €598.46
- Procedure base price
- €84,869.79
- Total effective price
- Not reported on Portal BASE
- Publication date
- 29 May 2025
- Award date
- 3 December 2024
- Signing date
- 2 January 2025
- Performance period
- 61 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7319779
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.